Eshaq, A.M.; Flanagan, T.W.; Ba Abbad, A.A.; Makarem, Z.A.A.; Bokir, M.S.; Alasheq, A.K.; Al Asheikh, S.A.; Almashhor, A.M.; Binyamani, F.; Al-Amoudi, W.A.;
et al. Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence. Int. J. Mol. Sci. 2025, 26, 88.
https://doi.org/10.3390/ijms26010088
AMA Style
Eshaq AM, Flanagan TW, Ba Abbad AA, Makarem ZAA, Bokir MS, Alasheq AK, Al Asheikh SA, Almashhor AM, Binyamani F, Al-Amoudi WA,
et al. Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence. International Journal of Molecular Sciences. 2025; 26(1):88.
https://doi.org/10.3390/ijms26010088
Chicago/Turabian Style
Eshaq, Abdulaziz M., Thomas W. Flanagan, Abdulqader A. Ba Abbad, Zain Alabden A. Makarem, Mohammed S. Bokir, Ahmed K. Alasheq, Sara A. Al Asheikh, Abdullah M. Almashhor, Faroq Binyamani, Waleed A. Al-Amoudi,
and et al. 2025. "Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence" International Journal of Molecular Sciences 26, no. 1: 88.
https://doi.org/10.3390/ijms26010088
APA Style
Eshaq, A. M., Flanagan, T. W., Ba Abbad, A. A., Makarem, Z. A. A., Bokir, M. S., Alasheq, A. K., Al Asheikh, S. A., Almashhor, A. M., Binyamani, F., Al-Amoudi, W. A., Bawzir, A. S., Haikel, Y., Megahed, M., & Hassan, M.
(2025). Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence. International Journal of Molecular Sciences, 26(1), 88.
https://doi.org/10.3390/ijms26010088
